Erb, H. H. H., Bodenbender, J., Handle, F., Diehl, T., Donix, L., Tsaur, I., . . . Thomas, C. (2020). Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. PLoS One.
Citación estilo ChicagoErb, Holger H. H., et al. "Assessment of STAT5 As a Potential Therapy Target in Enzalutamide-resistant Prostate Cancer." PLoS One 2020.
Cita MLAErb, Holger H. H., et al. "Assessment of STAT5 As a Potential Therapy Target in Enzalutamide-resistant Prostate Cancer." PLoS One 2020.
Precaución: Estas citas no son 100% exactas.